Clinical trial
Lethargic Depression Study
NCT00064467 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00064467 |
|---|---|
| Title | Lethargic Depression Study |
| Official title | An 8 Week, Multicenter, Randomized, Double-blind, Placebo Controlled Comparison of the Efficacy of Extended Release Bupropion Hydrochloride and Placebo in the Treatment of Adult Outpatients With Major Depressive Disorder With Lethargic Symptoms |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Major Depressive Disorder (MDD) |
| Intervention type | Drug |
| Interventions | Extended-release bupropion (HCl) |
| Enrollment | 268 |
| Start date | Jun 1, 2003 |
| Primary completion | May 1, 2005 |
| Completion | May 1, 2005 |
| First posted | Jul 10, 2003 |
| Last update posted | May 30, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: